For vitiligo patient, arthritis drug restores skin color
A medication for treating rheumatoid arthritis has restored skin color in a patient suffering from vitiligo, according to dermatologists at Yale School of Medicine. The disfiguring condition is best known as the disease that plagued late pop star Michael Jackson.
The finding was published June 24 inJAMA Dermatology.
Vitiligo is a common, psychologically devastating condition that causes skin to lose its pigmentation or color. Current treatments, such as steroid creams and light therapy, are not reliably effective in reversing the disease. Recent advances in vitiligo research led Yale investigators to consider an existing class of FDA-approved medications known as Janus kinase (JAK) inhibitors, as a possible treatment.
Last year,Dr. Brett King, assistant professor of dermatology and principal investigator of the research, broke new ground when he published a paper demonstrating the effectiveness of the JAK inhibitor to facitinib citrate in treating hair loss caused by alopecia areata. King and co-author Dr. Brittany Craiglow, believed the same medicine might be effective for vitiligo.
full article in the link below
http://news.yale.edu/2015/06/24/vitiligo-patient-arthritis-drug-restores-skin-color#
www.keralites.net |
Posted by: Ravi Narasimhan <ravi.narasimhan.in@gmail.com>
Reply via web post | • | Reply to sender | • | Reply to group | • | Start a New Topic | • | Messages in this topic (1) |
To subscribe send a mail to Keralites-subscribe@yahoogroups.com.
Send your posts to Keralites@yahoogroups.com.
Send your suggestions to Keralites-owner@yahoogroups.com.
To unsubscribe send a mail to Keralites-unsubscribe@yahoogroups.com.
Homepage: http://www.keralites.net
No comments:
Post a Comment